Associated Papers
Cytokine signaling defects in primary atopic diseases-an updated review.
Thakur V et al.
Frontiers in Allergy, 2025
JAK/STAT in human diseases: a common axis in immunodeficiencies and hematological disorders.
Djidjik R et al.
Frontiers in Immunology, 2025
41438753 (PubMed )
Supplement: Table1.pdf
Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma.
Bai B et al.
Blood Cancer Journal, 2024
39191762 (PubMed )
Supplement: 41408_2024_1124_MOESM2_ESM.xlsx › Table_S3
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma.
Ramirez CA et al.
Blood Advances, 2024
38713894 (PubMed )
Supplement: BLOODA_ADV-2022-007792-mmc6.xlsx › Supp_Table6
Identification of genetic subtypes in follicular lymphoma.
Shelton V et al.
Blood Cancer Journal, 2024
39112453 (PubMed )
Supplement: 41408_2024_1111_MOESM2_ESM.xlsx › ST5_-_mutations
Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease.
Sharma M et al.
The Journal of Experimental Medicine, 2023
Germline STAT6 gain-of-function variants cause severe allergy.
Yamashita M et al.
The Journal of Allergy and Clinical Immunology, 2023
A germline STAT6 gain-of-function variant is associated with early-onset allergies.
Suratannon N et al.
The Journal of Allergy and Clinical Immunology, 2023
Application of circulating tumour DNA in terms of prognosis prediction in Chinese follicular lymphoma patients.
Zhao M et al.
Frontiers in Genetics, 2023
37152994 (PubMed )
Supplement: Table3.XLSX › Raw_data
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Jiménez-Ubieto A et al.
Frontiers in Immunology, 2023
37342332 (PubMed )
Supplement: Table_2.xlsx › Sheet1
Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research Network.
Crouch S et al.
Blood Advances, 2022
35363872 (PubMed )
Supplement: BLOODA_ADV-2021-005284-mmc1.xlsx › S2_DLBCL_SNV
Panel Sequencing of Primary Cutaneous B-Cell Lymphoma.
Wobser M et al.
Cancers, 2022
36358692 (PubMed )
Supplement: cancers-14-05274-s001.zip › cancers-1895721-supplementary.xlsx › Supplementary_Table_S1
The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion.
Zamò A et al.
British Journal of Haematology, 2018
Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma.
Koues OI et al.
Immunity, 2015
25607463 (PubMed )
Supplement: 1-s2.0-S1074761314004889-mmc2.xlsx › Sheet2
Select a paper to view details